Clinical Data Milestone Highlights Potential for Cagent Vascular’s Peripheral Vascular Therapy

According to a recent LinkedIn post from Cagent Vascular Inc, the company is highlighting newly published, peer‑reviewed clinical data in the Journal of Endovascular Therapy. The post characterizes the publication as the largest reported series involving a specialty balloon in pedal vessels and suggests that its Serration Remodeling Therapy, or SRT, can be precisely delivered in below‑the‑ankle arteries with meaningful luminal gain and a favorable safety profile.

The post positions these results as significant for physicians treating patients at high risk of limb loss, emphasizing the combination of device deliverability and procedural control in challenging anatomy. For investors, such data may strengthen the company’s clinical credibility in limb‑salvage and endovascular therapy markets, potentially supporting future adoption, reimbursement discussions, and partnership or acquisition interest in the peripheral vascular device space.